Esophageal Squamous Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Esophageal Squamous Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Adbelimumab Combined With Chemotherapy and Apatinib in Patients With Resectable Esophageal Squamous Cell Carcinoma [Phase 2]
A Phase 2 neoadjuvant trial evaluating adbelimumab plus chemotherapy and apatinib for resectable esophageal squamous cell carcinoma is curre…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Serplulimab Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 study evaluating serplulimab in combination with chemotherapy as neoadjuvant therapy for resectable esophageal squamous cell carcino…
-
CLINICAL_TRIALS trial_result · 2025-12-01Clinical Trial Update: Study of Tislelizumab in Participants With Resectable Esophageal Squamous Cell Carcinoma [Phase 2]
BeiGene's tislelizumab was evaluated in a Phase 2 trial in patients with resectable esophageal squamous cell carcinoma; the study has comple…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer
This clinical trial update describes a noninvasive miRNA-based test being explored for screening gastrointestinal cancers. It is currently r…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: A Study of SYS6010, Enlonstobart, and Chemotherapy for First-Line Treatment of Esophageal Squamous Cell Carcinoma. [Phase 2, Phase 3]
A registry entry for a first-line treatment study of Esophageal Squamous Cell Carcinoma using SYS6010, Enlonstobart, and chemotherapy, spann…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: Stratified Treatment in Unresectable Locally Advanced ESCC Without Progression After Chemoimmunotherapy Induction Plus CCRT: Toripalimab Consolidation vs observation--a Prospective, Randomized, Controlled Phase III Multicenter Study [Phase 3]
A Phase III multicenter randomized trial comparing toripalimab consolidation versus observation in unresectable locally advanced esophageal …
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Selected Chemotherapy Combined Immunotherapy Treated High Risk Patient After NCRT in Resected Locally Advanced ESCC [Phase 2]
A Phase 2 clinical trial update describes using chemotherapy combined with immunotherapy for high-risk patients after neoadjuvant chemoradia…
-
CLINICAL_TRIALS trial_result · 2025-11-19Clinical Trial Update: Neoadjuvant Immunochemotherapy vs Chemoradiotherapy in ESCC [NA]
A clinical trial update indicates that a study comparing neoadjuvant immunochemotherapy to chemoradiotherapy in esophageal squamous cell car…
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: Surufatinib in Combination With Neoadjuvant Chemo-immunotherapy and Concurrent Chemoradiotherapy for Patients With Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 trial evaluating surufatinib in combination with toripalimab-based neoadjuvant chemo-immunotherapy and concurrent chemoradiotherapy …
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: Hypofractionated vs. Conventional Chemoradiotherapy After Induction Chemo-immunotherapy for Unresectable Esophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 clinical trial comparing hypofractionated versus conventional chemoradiotherapy after induction chemo-immunotherapy for unresectable…
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: Induction Immuno-chemotherapy and Concurrent Chemoradiotherapy With or Without Apatinib in Unresectable, Locally Advanced Esophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 clinical trial update evaluating induction immuno-chemotherapy and concurrent chemoradiotherapy with or without apatinib for unresec…
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: A Study to Evaluate LBL-007 in Combination With Tislelizumab Plus Chemotherapy in Participants With Unresectable Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma [Phase 2]
The document reports an ongoing Phase 2 clinical trial evaluating LBL-007 in combination with tislelizumab and chemotherapy for unresectable…
-
CLINICAL_TRIALS trial_result · 2025-11-05Clinical Trial Update: A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer [Phase 2]
Phase II trial evaluating the effect of itraconazole on pathologic complete response rates in resectable esophageal cancer is currently recr…
-
CLINICAL_TRIALS trial_result · 2025-10-16Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 clinical trial of INCB099318 in participants with advanced solid tumors has been terminated. The update reports safety, tolerability…
-
CLINICAL_TRIALS research · 2025-10-06Clinical Trial Update: Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers [NA]
A UCSF-led clinical trial is evaluating radiation therapy for metastatic gastrointestinal cancers, and the study is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-10-02Clinical Trial Update: A Study of IPM514 in Patients With Esophageal Squamous Cell Carcinoma. [Phase 1]
This is a Phase 1 trial update for IPM514 in patients with esophageal squamous cell carcinoma, with the study currently not yet recruiting.
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: A Single-arm, Open, Single-center Exploratory Study of Adebrelimab (SHR-1316) in Combination With Chemotherapy for the Perioperative Treatment of Locally Advanced Resectable Esophageal Squamous Carcinoma [Phase 2]
A Phase 2, single-arm, open-label exploratory trial evaluating adebrelimab (SHR-1316) in combination with chemotherapy for perioperative tre…
-
CLINICAL_TRIALS trial_result · 2025-10-02Clinical Trial Update: PPIO-005 The Relationship Between Different Nutritional Pathways and Tumor Outcomes After Minimally Invasive Esophagectomy
This completed clinical trial from Daping Hospital investigates how different nutritional pathways influence tumor outcomes after minimally …
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: A Retrospective Cohort Study of Patients Who Underwent Curative-intent Esophagectomy for ESCC at a Tertiary Referral Center in South Korea
A retrospective cohort study evaluating outcomes of patients with esophageal squamous cell carcinoma who underwent curative-intent esophagec…
-
CLINICAL_TRIALS trial_result · 2025-09-30Clinical Trial Update: Phase Ib Study of TNO155 in Combination With Spartalizumab or Ribociclib in Selected Malignancies [Phase 1]
Phase Ib study of TNO155 in combination with Spartalizumab or Ribociclib in selected malignancies was terminated, involving multiple indicat…
-
CLINICAL_TRIALS trial_result · 2025-09-30Clinical Trial Update: PPIO-007 Correlation Analysis of Type II Diabetes Mellitus on Short-term and Long-term Outcomes of Patients With Esophageal Squamous Cell Cancer Undergoing Minimally Invasive Esophagectomy
Completed study evaluating the correlation between Type II Diabetes Mellitus and short- and long-term outcomes after minimally invasive esop…
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: TAS-102 Plus Radiotherapy in Elderly ESCC [Phase 1, Phase 2]
This document reports a Phase 1/2 clinical trial evaluating TAS-102 in combination with radiotherapy for elderly patients with esophageal sq…
-
CLINICAL_TRIALS research · 2025-09-26Clinical Trial Update: SI-B001 Combined With Irinotecan in the Treatment of Recurrent Metastatic Esophageal Squamous Cell Carcinoma. [Phase 2]
Phase 2 clinical trial update evaluating SI-B001 in combination with irinotecan for recurrent metastatic esophageal squamous cell carcinoma.…
-
CLINICAL_TRIALS research · 2025-09-25Clinical Trial Update: Neoadjuvant Camrelizumab With Palbociclib for Resectable Esophageal Squamous Cell Carcinoma [Phase 2]
This is a Phase 2 neoadjuvant trial evaluating the combination of camrelizumab and palbociclib for resectable esophageal squamous cell carci…
-
CLINICAL_TRIALS research · 2025-09-23Clinical Trial Update: Ivonescimab Plus Short-Course Hypofractionated Radiotherapy as Second-Line Therapy for Esophageal Squamous Cell Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating Ivonescimab plus short-course hypofractionated radiotherapy as second-line therapy for esophageal squamo…